Valiant Laboratories Limited (NSE: VALIANTLAB)

Market Cap	5.19B
Revenue (ttm)	1.11B
Net Income (ttm)	-99.93M
Shares Out	43.45M
EPS (ttm)	-2.30
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	96,246
Open	115.50
Previous Close	117.27
Day's Range	114.99 - 117.44
52-Week Range	100.20 - 214.95
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 12, 2024

About Valiant Laboratories

Valiant Laboratories Limited operates as an active pharmaceutical ingredient/bulk drug manufacturing company in India and internationally. The company manufactures paracetamol in various grades, such as Indian/British/European/the United States pharmacopoeias for the treatment of headaches, muscle aches, arthritis, back aches, toothaches, cold, and fever. It also offers specialty chemicals. The company was formerly known as Bharat Chemicals and changed its name to Valiant Laboratories Limited in August 2021. The company was founded in 1980 and ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1980
• Employees: 77
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: VALIANTLAB

Financial Performance

In 2023, Valiant Laboratories's revenue was 1.82 billion, a decrease of -45.48% compared to the previous year's 3.34 billion. Earnings were 3.20 million, a decrease of -98.90%.